Оценка роли сывороточного релаксина в развитии нарушений мочеиспускания во время беременности
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Список литературы
1. Аполихина И.А. Современный механизм идентификации факторов риска недержания мочи у женщин. Журн. Рос. ассоц. акуш.-гин. 2003; 1: 14–8.
2. Лоран О.Б. Эпидемиология, этиология, патогенез, диагностика недержания мочи. Материалы пленума правления Российского общества урологов. Ярославль, 21–24 мая 2001. М., 2001; с. 21–41.
3. Bani D. Relaxin: a pleiotropic hormone. Gen Pharmacol 1997; 28: 13–22.
4. Bani D, Failli P, Grazia M. Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture. Hypertension 1998; 31: 1240–7.
5. Brummen HJ, Bruinse HW, Bom JG et al. How do the prevalences of urogenital symptoms change during pregnancy? Neurourol Urodyn 2006; 25: 135–9.
6. Cardozo L, Staskin D. Pregnancy and childbirth. Textbook of female Urology and Urogynaecologyю. UK, 2002; p. 977–94.
7. Chaliha C, Bland J, Monga A. Pregnancy and delivery: a urodynamic viewpoint. Br J Obst Gynec 2000; 107: 1354–9.
8. Chaliha C, Stanton SL. Urological problems in pregnancy. BJU Int. 2002; 89: 469–76.
9. Chapple C, MacDiarmid S. Lower urinary tract symptoms in pregnancy. Urodynamics made easy 2000; 211: 149–53.
10. Cutner A, Carey A, Cardoso L. Lower urinary tract symptoms in early pregnancy. Br J Obstet Gynecol 1992; 89: 75–8.
11. Danielson L, Sherwood O, Conrad K. Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest 1999; 103: 525–33.
12. Dschietziq T, Teichman S, Unemori E et al. First clinical experience with intravenous recombinant human relaxin in compensated heart failure. Ann N. Y. Acad Sci 2009; p. 387–92.
13. FitzGerald M, Graziano S. Anatomic and functional changes of the lower urinary tract during pregnancy. Urol Clin North Am 2007; 34: 7–12.
14. Granese R, Adile B. Urinary incontinence in pregnancy and in puerperium: 3 months follow-up after delivery. Minerva Ginecol 2008; 60: 15–21.
15. Hojberg K, Salvig J, Winslow N. Urinary incontinence: prevalence and risk factors at 16 weeks of gestation. Br J Obstet Gynecol 1999; 106: 842–50.
16. Kristiansson P, Samuelsson E, Schoults BV et al. Acta Reproductive hormones and stress urinary incontinence in pregnancy. Obstet Gynecol Scand 2004; 80: 1125–30.
17. Kristiansson P, Svardsudd K, Schoultz B. Serum relaxin, symphyseal pain and back pain during pregnancy. Am J Obstet Gynecol 1996; 175: 1342–7.
18. Ma S, Gundlach A. Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies. Adv Exp Med Biol 2007; 612: 119–37.
19. Min G, Hartzog M, Jennings R. Evidence that endogenous relaxin promotes growth of the vagina and uterus during pregnancy in gilts. Endocrinology 1997; 138: 560–5.
20. Minassian V, Stewart W, Wood G. Urinary incontinence in women: variation in prevalence estimates and risk factors Obstet Gynecol 2008; 111: 324–31.
21. Moller A, Lose G, Jorgensen T. Risk factors for the lower urinary tract symptoms in women 40 to 60 years of age. Obstet Gynecol 2000; 96: 446–51.
22. Pregazzi R, Sartore A, Troiano L. Postpartum urinary symptoms: prevalence and risk factors. Eur J Obstet Gynecol Reprod Biol 2002; 103: 179–82.
23. Santos P, Mendoca D, Alves O et al. Prevalence and impact of stress urinary incontinence before and during pregnancy. Acta Med Port 2006; 19: 349–56.
24. Sibi M, Newton R. The urinary tract in pregnancy. Urogynecol Reconstruct Pelvic Surg 2007; 599: 472–90.
25. Toozs-Hobson P, Khullar V, Cardozo L. Three-dimensional ultrasound: a novel technique for investigating the urethral sphincter in the third trimester of pregnancy. Ultrasound Obst Gynecol 2001; 17: 421–4.
26. Viktrup L, Rortveit G, Lose G. Risk of stress urinary incontinence twelve years after the first pregnancy and delivery. Obstet Gynecol 2006; 108: 248–54.
27. Wen Y, Zhao Y, Polan M. Effect of relaxin on TGF-beta 1 expression in cultured vaginal fibroblasts from women with stress urinary incontinence. Reprod Sci 2008; 15: 312–20.
28. Wesnes S, Rortveit G, Bo K. Urinary incontinence during pregnancy. Obstet Gynecol 2007; 109: 922–8.
29. Wijma J, Weis A, Wolf B. Anatomical and functional changes in the lower urinary tract during pregnancy. Br J Obstet Gynecol 2001; 108: 726–32.
2. Лоран О.Б. Эпидемиология, этиология, патогенез, диагностика недержания мочи. Материалы пленума правления Российского общества урологов. Ярославль, 21–24 мая 2001. М., 2001; с. 21–41.
3. Bani D. Relaxin: a pleiotropic hormone. Gen Pharmacol 1997; 28: 13–22.
4. Bani D, Failli P, Grazia M. Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture. Hypertension 1998; 31: 1240–7.
5. Brummen HJ, Bruinse HW, Bom JG et al. How do the prevalences of urogenital symptoms change during pregnancy? Neurourol Urodyn 2006; 25: 135–9.
6. Cardozo L, Staskin D. Pregnancy and childbirth. Textbook of female Urology and Urogynaecologyю. UK, 2002; p. 977–94.
7. Chaliha C, Bland J, Monga A. Pregnancy and delivery: a urodynamic viewpoint. Br J Obst Gynec 2000; 107: 1354–9.
8. Chaliha C, Stanton SL. Urological problems in pregnancy. BJU Int. 2002; 89: 469–76.
9. Chapple C, MacDiarmid S. Lower urinary tract symptoms in pregnancy. Urodynamics made easy 2000; 211: 149–53.
10. Cutner A, Carey A, Cardoso L. Lower urinary tract symptoms in early pregnancy. Br J Obstet Gynecol 1992; 89: 75–8.
11. Danielson L, Sherwood O, Conrad K. Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest 1999; 103: 525–33.
12. Dschietziq T, Teichman S, Unemori E et al. First clinical experience with intravenous recombinant human relaxin in compensated heart failure. Ann N. Y. Acad Sci 2009; p. 387–92.
13. FitzGerald M, Graziano S. Anatomic and functional changes of the lower urinary tract during pregnancy. Urol Clin North Am 2007; 34: 7–12.
14. Granese R, Adile B. Urinary incontinence in pregnancy and in puerperium: 3 months follow-up after delivery. Minerva Ginecol 2008; 60: 15–21.
15. Hojberg K, Salvig J, Winslow N. Urinary incontinence: prevalence and risk factors at 16 weeks of gestation. Br J Obstet Gynecol 1999; 106: 842–50.
16. Kristiansson P, Samuelsson E, Schoults BV et al. Acta Reproductive hormones and stress urinary incontinence in pregnancy. Obstet Gynecol Scand 2004; 80: 1125–30.
17. Kristiansson P, Svardsudd K, Schoultz B. Serum relaxin, symphyseal pain and back pain during pregnancy. Am J Obstet Gynecol 1996; 175: 1342–7.
18. Ma S, Gundlach A. Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies. Adv Exp Med Biol 2007; 612: 119–37.
19. Min G, Hartzog M, Jennings R. Evidence that endogenous relaxin promotes growth of the vagina and uterus during pregnancy in gilts. Endocrinology 1997; 138: 560–5.
20. Minassian V, Stewart W, Wood G. Urinary incontinence in women: variation in prevalence estimates and risk factors Obstet Gynecol 2008; 111: 324–31.
21. Moller A, Lose G, Jorgensen T. Risk factors for the lower urinary tract symptoms in women 40 to 60 years of age. Obstet Gynecol 2000; 96: 446–51.
22. Pregazzi R, Sartore A, Troiano L. Postpartum urinary symptoms: prevalence and risk factors. Eur J Obstet Gynecol Reprod Biol 2002; 103: 179–82.
23. Santos P, Mendoca D, Alves O et al. Prevalence and impact of stress urinary incontinence before and during pregnancy. Acta Med Port 2006; 19: 349–56.
24. Sibi M, Newton R. The urinary tract in pregnancy. Urogynecol Reconstruct Pelvic Surg 2007; 599: 472–90.
25. Toozs-Hobson P, Khullar V, Cardozo L. Three-dimensional ultrasound: a novel technique for investigating the urethral sphincter in the third trimester of pregnancy. Ultrasound Obst Gynecol 2001; 17: 421–4.
26. Viktrup L, Rortveit G, Lose G. Risk of stress urinary incontinence twelve years after the first pregnancy and delivery. Obstet Gynecol 2006; 108: 248–54.
27. Wen Y, Zhao Y, Polan M. Effect of relaxin on TGF-beta 1 expression in cultured vaginal fibroblasts from women with stress urinary incontinence. Reprod Sci 2008; 15: 312–20.
28. Wesnes S, Rortveit G, Bo K. Urinary incontinence during pregnancy. Obstet Gynecol 2007; 109: 922–8.
29. Wijma J, Weis A, Wolf B. Anatomical and functional changes in the lower urinary tract during pregnancy. Br J Obstet Gynecol 2001; 108: 726–32.
Авторы
В.Е.Балан, Л.А.Ковалева
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.